Tags : Manufacturing Facilities

Biocon Receives EMA’s GMP Certification for Multiple Biosimilars Manufacturing Facilities

Shots: Biocon has received the EMA’s Certificate of GMP compliance for multiple biologics drug substance (DS) and drug product (DP) manufacturing facilities at Biocon Park, Bengaluru. The facilities are used for the manufacture biosimilars: bevacizumab, trastuzumab, pegfilgrastim and secondary packaging of Insulin Glargine for EU and were inspected in Mar’2020 The approval expands Biocon’s capabilities […]Read More